SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-040317
Filing Date
2022-11-07
Accepted
2022-11-07 16:30:34
Documents
13
Period of Report
2022-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10043673_8k.htm   iXBRL 8-K 40425
2 EXHIBIT 10.1 brhc10043673_ex10-1.htm EX-10.1 41167
  Complete submission text file 0001140361-22-040317.txt   233849

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aryd-20221107.xsd EX-101.SCH 3884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aryd-20221107_lab.xml EX-101.LAB 23291
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aryd-20221107_pre.xml EX-101.PRE 16565
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043673_8k_htm.xml XML 4251
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 212-284-2300
ARYA Sciences Acquisition Corp IV (Filer) CIK: 0001838821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40122 | Film No.: 221365876
SIC: 2836 Biological Products, (No Diagnostic Substances)